Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).
| CEO: |
Chris Tovey |
| Non-Executive Director: |
Aled Williams, Nigel Brooksby, Debra Barker, James Stearns |
| Non-Executive Chairman: |
Nigel Rudd |
| CFO and Company Secretary: |
Shaun Claydon |
| Chief Scientific Officer: |
William Love |
| Address: |
Unit 36 Sussex Innovation Centre, Science Park Square, Falmer, Brighton, United Kingdom |
| Phone: |
+44 (0)1273 704 440 |
| Fax: |
|
| Website: |
http://www.destinypharma.com/ |
| Email: |
|